 |
 |
Laura DeForge Senior Scientist: Assay & Automation Technology |
"I joined Genentech in September of 1994. I was focused primarily on the anti-IL-8 project at the time and found it very exciting to be collaborating with scientists whose work I had admired while I was a postdoc working on IL-8 biology. Years later, I still find that the combination of fast-paced, quality work and collaboration with world-class scientists creates a very challenging and gratifying work environment."
Current Projects "In my group, as in much of AAT as a whole, we develop assays needed to help move Research projects forward into development. We use many approaches, including traditional ELISAs, various solution phase binding technologies, enzymatic assays, and many types of cell-based assays, including cell binding, proliferation, and primary leukocyte response assays. We also evaluate and implement new technologies, including approaches to multiplexed protein analysis. The primary focus of my group is currently on immunology-related projects."
Collaborations "I have collaborated most frequently with scientists in Immunology, Protein Engineering, Antibody Engineering, and Molecular Oncology, both individually and at the level of project teams. AAT also interacts extensively with investigators outside of Research, mainly from departments within Development Sciences and Process Sciences. The environment is open and collaborative, and people at Genentech are consistently willing to share their knowledge."
Inspiration/Vision "I find it very rewarding to be involved in identifying new therapeutic proteins, particularly given Genentech's proven success in bringing novel therapeutics to patients. Other aspects of my job that I truly appreciate include the continual opportunities for learning and the challenges in solving complex analytical problems."